Asthma

  • Gary C. Kindt
Part of the Contemporary Internal Medicine book series (COIM, volume 3)

Abstract

This was the second Ohio State University Hospitals admission for this 28-year-old woman admitted with one week of increasing dyspnea and wheezing. She reported a history of asthma dating back to childhood, with many hospital admissions up to the age of thirteen. Since that time, she remained in good health, with the exception of a single hospitalization for an acute exacerbation two years prior to admission. She had never required mechanical ventilation. She was in her usual state of health until two weeks prior to admission, when she noted symptoms of an upper respiratory tract infection and a nonproductive cough. During the week prior to admission, she noted increasing dyspnea, especially with exertion, and audible expiratory wheezing. There had been no fever, chills, or chest pain. There was neither a history of sensitivity to aspirin nor a history of hay fever.

Keywords

Force Vital Capacity Airway Smooth Muscle Allergy Clin Immunol Total Lung Capacity Acute Asthma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Thoracic Society: Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis. 1962;85:762.Google Scholar
  2. 2.
    Kelsen SG, Kelsen DP, Fleeger BF, et al: Emergency room assessment and treatment of patients with acute asthma: Adequacy of the conventional approach. Am J Med. 1978;64:622.PubMedCrossRefGoogle Scholar
  3. 3.
    McFadden ER Jr, Lyons HA: Arterial-blood gas tension in asthma. N Engl J Med. 1968;278:1027.PubMedCrossRefGoogle Scholar
  4. 4.
    Weiss EB, Faling LJ: Clinical significance of PaCO2 during status asthma: The cross-over point. Ann Allergy. 1968;26:545.PubMedGoogle Scholar
  5. 5.
    Houston JC, DeNavasquez S, Trounce JR: A clinical and pathological study of fatal cases of status asthmaticus. Thorax. 1953;8:207–213.PubMedCrossRefGoogle Scholar
  6. 6.
    Hogg JC: The pathology of asthma. Clin Chest Med. 1984;5:567.PubMedGoogle Scholar
  7. 7.
    Dunnill MS, Massarella GR, Anderson JA: A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax. 1969;24:176.PubMedCrossRefGoogle Scholar
  8. 8.
    De Monchy JGR, Kauffman HF, Venge P, et al: Bronchoalveolar eosinophilia during alleren-induced late asthmatic reactions. Am Rev Respir Dis. 1985;131:373–376.PubMedGoogle Scholar
  9. 9.
    Tomoika M, Ida S, Shindoh Y, et al: Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis. 1984;129:1000–1005.Google Scholar
  10. 10.
    Drazen JM: Chemical mediators of immediate hypersensitivity reactions, in Fishman AP, Macklem PT, Mead J (eds): Handbook of Physiology. Bethesda, American Physiological Society, 1985, pp 711–718.Google Scholar
  11. 11.
    Serafin WE, Austin KF: Mediators of immediate hypersensitivity reactions. N Engl J Med. 1987;317:30.PubMedCrossRefGoogle Scholar
  12. 12.
    Frigas E, Gleich GJ: The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol. 1986;77:527.PubMedCrossRefGoogle Scholar
  13. 13.
    Boushey HA, Holzman MJ, Sheller JR, et al: Bronchial hyperreactivity. Am Rev Respir Dis. 1980;121:389–413.PubMedGoogle Scholar
  14. 14.
    Barnes PJ: Adrenergic receptors of normal and asthmatic airways. Eur J Respir Dis. 1984;65(Suppl 135):72–79.Google Scholar
  15. 15.
    Paterson JW, Lulich KM, Goldie RG: The role of B-adrenoceptors in bronchial hyperreactivity, in Morley J (ed): Perspectives in Asthma: Bronchial Hyperreactivity. New York, Academic Press, 1982, pp 19–37.Google Scholar
  16. 16.
    Black JL, Salome CM, Yan K, et al: Comparison between airways response to an alpha-adrenoceptor agonist and histamine in asthmatic and non-asthmatic subjects. Br J Clin Pharmacol. 1982;14:464–466.PubMedCrossRefGoogle Scholar
  17. 17.
    Partanen M, Laitenen A, Hervonen A, et al: Catecholamine and acetyl cholinesterase containing nerves in human lower respiratory tract. Histochemistry. 1982;76:175–188.PubMedCrossRefGoogle Scholar
  18. 18.
    Pride NB: Physiology of asthma. In: Clark TJH, Godfrey S (eds): Asthma. London, Chapman and Hall, 1983,12–56.Google Scholar
  19. 19.
    Benatar SR: Fatal asthma. N Engl J Med. 1986;314:423–429.PubMedCrossRefGoogle Scholar
  20. 20.
    O’Conner GT, Weiss ST, Speizer FE: The epidemiology of asthma, in Gershwin ME (ed): Bronchial Asthma: Principles of diagnosis and Treatment. Orlando, Grune & Stratton Inc, 1986, p 3.Google Scholar
  21. 21.
    Gregg I: Epidemiological aspects. In: Clark TJH, Godfrey S (eds): Asthma. London, Chapman & Hall, 1983, pp 242–284.Google Scholar
  22. 22.
    Waite DA, Eyles EF, Tonkin SL, et al: Asthma prevalence in Tokelauan children in two environments. Clin Allergy. 1980;10:71–75.PubMedCrossRefGoogle Scholar
  23. 23.
    Speizer FE, Doll R, Heaf P: Observations on recent increase in mortality from asthma. Br Med J. 1968;1:335–339.PubMedCrossRefGoogle Scholar
  24. 24.
    Sly RM: Increases in deaths from asthma. Ann Allergy. 1984;53:20–25.PubMedGoogle Scholar
  25. 25.
    Barriot P, Riou B: Prevention of fatal asthma. Chest. 1987;92:460–466.PubMedCrossRefGoogle Scholar
  26. 26.
    Robin ED, Lewiston N: Unexpected, unexplained sudden death in young asthmatic subjects. Chest. 1989;96:790–793.PubMedCrossRefGoogle Scholar
  27. 27.
    Rackemann FM, Edwards MC: Asthma in children. N Engl J Med. 1952;246:815–823.PubMedCrossRefGoogle Scholar
  28. 28.
    Bronnimann S, Burrows B: A prospective study of the natural history of asthma: Remission and relapse rates. Chest. 1986;90:480–484.PubMedCrossRefGoogle Scholar
  29. 29.
    Mountain RD, Sahn SA: Clinical features and outcome in patients with acute asthma presenting with hypercapnea. Am Rev Respir Dis. 1988;138:535–539.PubMedCrossRefGoogle Scholar
  30. 30.
    Barnes PJ: A new approach to the treatment of asthma. N Engl J Med. 1989;321:1517–1527.PubMedCrossRefGoogle Scholar
  31. 31.
    Carstairs JR, Nimmo AJ, Barnes PJ: Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis. 1985;132:541–547.PubMedGoogle Scholar
  32. 32.
    Butchers PR, Skidmore IF, Vardey CJ, et al: Characterization of the receptor mediating the antianaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmacol. 1980;71:663–667.PubMedCrossRefGoogle Scholar
  33. 33.
    Koeter GH, Postma DS, Keyzer JJ, et al: The effects of oral slow-release terbutaline on early morning dyspnoea. Eur J Clin Pharmacol. 1985;28:159–162.PubMedCrossRefGoogle Scholar
  34. 34.
    Nelson HS: Adrenergic therapy of bronchial asthma. J Allergy Clin Immunol. 1986;77:771–785.PubMedCrossRefGoogle Scholar
  35. 35.
    Tattersfield AE: Tolerance to beta-agonists. Bull Eur Physiopathol Respir. 1985;21:1s–5s.PubMedGoogle Scholar
  36. 36.
    Church MK, Featherstone RL, Cushley MJ, et al: Relationships between adenosine, cyclic nucleotides, and xanthines in asthma. J Allergy Clin Immunol. 1986;78:670–675.PubMedCrossRefGoogle Scholar
  37. 37.
    Rafferty P, Beasley R, Holgate ST: Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution. Thorax. 1988;43:446–450.PubMedCrossRefGoogle Scholar
  38. 38.
    Morris HG: Mechanisms of action and therapeutic role of corticosteroids in asthma. J Allergy Clin Immunol. 1985;75:1–13.PubMedCrossRefGoogle Scholar
  39. 39.
    Pauwels R: Mode of action of corticosteroids in asthma and rhinitis. Clin Allergy. 1986;16:281–288.PubMedCrossRefGoogle Scholar
  40. 40.
    Blackwell GJ, Carnuccio R, Di Rosa M, et al: Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980;287:147–149.PubMedCrossRefGoogle Scholar
  41. 41.
    Boschetto P, Rogers DF, Barnes PJ: Inhibition of airway microvascular leakage by corticosteroids. Thorax. 1989;44:320P–321P (abstr).Google Scholar
  42. 42.
    Townley RG, Reeb R, Fitzgibbons T, et al: The effects of corticosteroids on beta-adrenergic receptors in bronchial smooth muscle. J Allergy. 1970;45:118–121 (abstr).CrossRefGoogle Scholar
  43. 43.
    Baigelman W, Chodosh S, Pizzuto D, et al: Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am J Med. 1983;75:929–936.PubMedCrossRefGoogle Scholar
  44. 44.
    Fanta CH, Rossing TH, McFadden ER: Glucocorticoids in acute asthma: A critical controlled trial. Am J Med. 1983;74:845–851.PubMedCrossRefGoogle Scholar
  45. 45.
    Haskell RJ, Wong BM, Hansen JE: A double blind randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med. 1983;143:1324–1327.PubMedCrossRefGoogle Scholar
  46. 46.
    Littenberg B, Gluck EH: A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986;314:150–152.PubMedCrossRefGoogle Scholar
  47. 47.
    Harrison BD, Stokes TC, Hart GJ: Need for intravenous hydrocortisone in addition to oral prednisone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet. 1986;1(8474): 181–184.PubMedCrossRefGoogle Scholar
  48. 48.
    Ratto D, Alfaro C, Sipsey J, et al: Are intravenous corticosteroids required in status asthmaticus?. JAMA. 1988;260:527–529.PubMedCrossRefGoogle Scholar
  49. 49.
    Li JTC, Reed CE: Proper use of aerosol corticosteroids to control asthma. Mayo Clin Proc. 1989;64:205–210.PubMedCrossRefGoogle Scholar
  50. 50.
    Smyllie HC, Connolly CK: Incidence of serious complications of corticosteroid therapy in respiratory disease. A retrospective survey of patients in the Brompton Hospital. Thorax. 1968;23:571–581.Google Scholar
  51. 51.
    Konig P: Inhaled corticosteroids—their present and future role in the management of asthma. J Allergy Clin Immunol. 1988;82:297–306.PubMedCrossRefGoogle Scholar
  52. 52.
    Anderson SD, Seale JP, Ferris L, et al: An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol. 1979;64:612–624.PubMedCrossRefGoogle Scholar
  53. 53.
    Mullarkey MF, Blumenstein BA, Andrde WP, et al: Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. N Engl J Med. 1988;318:603–607.CrossRefGoogle Scholar
  54. 54.
    Bernstein DI, Bernstein IL, Bodenheimer SS, et al: An open study of auranofin in the treatment of steroid-dependent asthma. J Allergy Clin Immunol. 1988;81:6–16.PubMedCrossRefGoogle Scholar
  55. 55.
    Lichtenstein LM, Valentine MD, Norman PS: A reevaluation of immunotherapy for asthma. Am Rev Respir Dis. 1984;129:657–659.PubMedGoogle Scholar
  56. 56.
    Dannaeus A: Diet and asthma in infancy and childhood. Eur J Respir Dis. 1984;65(Suppl 136): 165–167.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Gary C. Kindt

There are no affiliations available

Personalised recommendations